TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q3 2024 vs. Q2 2024
How the institutions holding TriSalus Life Sciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 27 | 1 | 31 | +5 |
| Shares | 1.79M | 30.3K | 2.17M | +416.4K (+23.7%) |
| Value | $9.20M | $167.1K | $10.0M | +$974.1K (+10.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealthcare Advisory Partners LLC | 643,740 | $2.97M | 0.08% |
| MSD Partners, L.P. | 39,999 | $184.4K | 0.12% |
| BlackRock, Inc. | 30,270 | $139.5K | 0.00% |
| Vestcor Inc | 23,376 | $108.0K | 0.00% |
| Angelo Gordon & Co., L.P. | 20,854 | $96.1K | 0.03% |
| Virtu Financial LLC | 19,875 | $92.0K | 0.01% |
| Bridgeway Capital Management, LLC | 15,000 | $69.2K | 0.00% |
| Gilder Gagnon Howe & Co LLC | 14,440 | $66.6K | 0.00% |
| Walleye Capital LLC | 14,376 | $66.3K | 0.00% |
| Magnetar Financial LLC | 14,232 | $65.6K | 0.00% |
| Two Sigma Securities, LLC | 10,192 | $47.0K | 0.00% |
Sold out (6)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Highbridge Capital Management LLC | 214,545 | $1.18M |
| Anson Capital, Inc. | 24,415 | $134.8K |
| Goldman Sachs Group Inc | 23,045 | $127.2K |
| GPS Wealth Strategies Group, LLC | 233 | $1.29K |
| Deerfield Management Company, L.P. (Series C) | 1 | $6 |
| Clear Street LLC | 1 | $6 |
Not filed for Q3 2024 yet (1)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 30,270 | $167.1K |